Schedules for hepatitis B vaccination of risk groups: balancing immunogenicity and compliance
- 11 July 2007
- journal article
- review article
- Published by BMJ in Sexually Transmitted Infections
- Vol. 83 (6) , 426-432
Abstract
Introduction: Vaccination is an important tool in hepatitis B prevention. However, several vaccine doses are required to induce long-term protection. Several at-risk groups have difficulties in adhering to the standard vaccination schedule. Objectives: This paper aims to review the use of accelerated hepatitis B vaccination schedules, in terms of immunogenicity and compliance. Results: Accelerated schedules (0.1.2.12 months) or super-accelerated schedules (0.7.21.360 days) have been shown to result in higher proportions of healthy vaccinees reaching anti-HBs antibody levels ⩾10 IU/l more rapidly. A fourth completing dose is required to lift antibody levels to an equal height, as does a standard (0.1.6 months) schedule. Accelerated schedules do also increase the uptake of hepatitis B vaccine, that is the proportion of vaccinees who receive three doses. However, completing the schedule with a fourth dose is usually more difficult than completing a standard 0.1.6-month schedule. Several additional tools can help to increase the compliance (eg, reminder systems, outreach services and incentive schemes). Conclusion: For rapid seroconversion and almost immediate protection in the short term, a (super)accelerated schedule could be used in at-risk groups. As long-term protection data with these (super) accelerated schedules have not been documented yet, a fourth dose at month 12 is still required. A shortened schedule (0.1.4 months) might be an alternative worth considering compared with the standard 0.1.6, as it convenes to internationally accepted minimum dose intervals and offers earlier protection. There is a clear need to study the long-term protection and effectiveness of the primary part of (super)accelerated schedules.Keywords
This publication has 51 references indexed in Scilit:
- Monitoring the effectiveness of HIV and STI prevention initiatives in England, Wales, and Northern Ireland: where are we now?Sexually Transmitted Infections, 2006
- Patient reminder and recall systems to improve immunization ratesCochrane Database of Systematic Reviews, 2005
- Audit on offering and accepting hepatitis B vaccine by sex workersInternational Journal of STD & AIDS, 2004
- A randomized controlled trial of monetary incentives vs. outreach to enhance adherence to the hepatitis B vaccine series among injection drug usersDrug and Alcohol Dependence, 2003
- Accelerated hepatitis B vaccination schedule in childhoodPediatrics International, 2002
- Results of an enhanced-outreach programme of hepatitis B vaccination in the Netherlands (1998–2000) among men who have sex with men, hard drug users, sex workers and heterosexual persons with multiple partnersJournal of Hepatology, 2002
- Are booster immunisations needed for lifelong hepatitis B immunity? European Consensus Group on Hepatitis B Immunity.2000
- The Anti-HBs Response After 2 Different Accelerated Intradermal and Intramuscular Schemes for Hepatitis B VaccinationScandinavian Journal of Infectious Diseases, 1999
- Immunogenicity of Two Doses of Yeast Recombinant Hepatitis B Vaccine in Healthy Older AdultsThe Journal of Infectious Diseases, 1997
- Comparison of a rapid hepatitis B immunization schedule to the standard schedule for adults.1996